The investigation of tripeptide aldehydes as reversible covalent inhib
itors of human rhinovirus (HRV) 3C protease (3CP) is reported. Molecul
ar models based on the apo crystal structure of HRV-14 3CP and other t
rypsin-like serine proteases were constructed to approximate the bindi
ng of peptide substrates, generate transition state models of P-1-P-1'
amide cleavage, and propose novel tripeptide aldehydes. Glutaminal de
rivatives have limitations since they exist predominantly in the cycli
c hemiaminal form. Therefore, several isosteric replacements for the P
-1 carboxamide side chain were designed and incorporated into the trip
eptide aldehydes. These compounds were found to be potent inhibitors o
f purified HRV-14 3CP with K(i)s ranging from 0.005 to 0.64 mu M. Seve
ral have low micromolar antiviral activity when tested against HRV-14-
infected H1-HeLa cells. The N-acetyl derivative 3 was also shown to be
active against HRV serotypes 2, 16, and 89. High-resolution cocrystal
structures of HRV-8 3CP, covalently bound to compounds 3, 15, and 16,
were solved. These cocrystal structures were analyzed and compared wi
th our original HRV-14 3CP-substrate and inhibitor models.